R. Day

799 total citations
10 papers, 622 citations indexed

About

R. Day is a scholar working on Molecular Biology, Spectroscopy and Pulmonary and Respiratory Medicine. According to data from OpenAlex, R. Day has authored 10 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Spectroscopy and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in R. Day's work include Mass Spectrometry Techniques and Applications (4 papers), Advanced Proteomics Techniques and Applications (3 papers) and Lung Cancer Treatments and Mutations (3 papers). R. Day is often cited by papers focused on Mass Spectrometry Techniques and Applications (4 papers), Advanced Proteomics Techniques and Applications (3 papers) and Lung Cancer Treatments and Mutations (3 papers). R. Day collaborates with scholars based in France, Canada and United States. R. Day's co-authors include Isabelle Fournier, Michel Salzet, R. Lemaire, Annie Desmons, Maxence Wisztorski, J. C. Tabet, Larry Norton, Jonathan Stauber, Julien Franck and David Bonnel and has published in prestigious journals such as Analytical Chemistry, Journal of Proteome Research and Lung Cancer.

In The Last Decade

R. Day

10 papers receiving 603 citations

Peers

Countries citing papers authored by R. Day

Since Specialization

Citations

This map shows the geographic impact of R. Day's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Day with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Day more than expected).

Fields of papers citing papers by R. Day

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Day. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Day. The network helps show where R. Day may publish in the future.

Co-authorship network of co-authors of R. Day

This figure shows the co-authorship network connecting the top 25 collaborators of R. Day. A scholar is included among the top collaborators of R. Day based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Day. R. Day is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Polymerase Chain Reaction and Immunoassay−Matrix Assisted Laser Desorption Mass Spectrometry Using Tag-Mass Technology: New Tools to Break Down Quantification Limits and Multiplexes 2009 ·Analytical Chemistry ·Jonathan Stauber, Mohamed El Ayed, Maxence Wisztorski, R. Day, Isabelle Fournier, Michel Salzet	9
2	MALDI Imaging of Formalin-Fixed Paraffin-Embedded Tissues: Application to Model Animals of Parkinson Disease for Biomarker Hunting 2008 ·Journal of Proteome Research ·Jonathan Stauber, R. Lemaire, Julien Franck, David Bonnel, Dominique Croix, R. Day, Maxence Wisztorski, Isabelle Fournier, Michel Salzet	125
3	Direct Analysis and MALDI Imaging of Formalin-Fixed, Paraffin-Embedded Tissue Sections 2007 ·Journal of Proteome Research ·R. Lemaire, Annie Desmons, (unknown), R. Day, Michel Salzet, Isabelle Fournier	242
4	MALDI-MS Direct Tissue Analysis of Proteins: Improving Signal Sensitivity Using Organic Treatments 2006 ·Analytical Chemistry ·R. Lemaire, Maxence Wisztorski, Annie Desmons, J. C. Tabet, R. Day, Michel Salzet, Isabelle Fournier	143
5	242 Promising long term outcome of weekly paclitaxel and carboplatin with simultaneous thoracic radiotherapy (TRT) for locally advanced non-small cell lung cancer (NSCLC) 1997 ·Lung Cancer ·Chandra P. Belani, Joseph Aisner, R. Day, R. K. Ramanathan, (unknown), (unknown), (unknown), (unknown)	17
6	38 Topotecan and paclitaxel in extensive stage small cell lung cancer (ED-SCLC) patients without prior therapy 1997 ·Lung Cancer ·(unknown), R. Day, Mark L. Levitt, George W. Woolley, (unknown)	17
7	HLA-DQ1 is associated with clinical response and survival of patients with melanoma who are treated with interleukin-2. 1995 ·PubMed ·(unknown), R. Day, R Duquesnoy, (unknown), Sylvia Adams, Jinwon Lee, (unknown)	12
8	Potential innovations in scheduling of cancer chemotherapy. 1991 ·PubMed ·Larry Norton, R. Day	35
9	Chemotherapy for metastatic non-small cell bronchogenic carcinoma: cyclophosphamide, doxorubicin, and etoposide versus mitomycin and vinblastine (EST 2575, generation IV). 1984 ·PubMed ·(unknown), R. Day, (unknown), (unknown), (unknown)	14
10	Experiences with corticotrophin (ACTH) in the acute stage of retrolental fibroplasia. 1951 ·PubMed ·(unknown), (unknown), R. Day, (unknown)	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact